A 32-bp deletion within the CCR5 locus protects against transmission of parenterally acquired human immunodeficiency virus but does not affect progression to AIDS-defining illness

Journal of Infectious Diseases

Volumn 178, Issue 4, 1998, Pages 1163-1166

  Wilkinson, David A ^a   Operskalski, Eva A ^b   Busch, Michael P ^b   Mosley, James W ^b   Koup, Richard A ^b  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AIDS RELATED COMPLEX; ARTICLE; BLOOD TRANSFUSION; DISEASE COURSE; DISEASE TRANSMISSION; GENE DELETION; GENE LOCUS; GENOTYPE; HEMOPHILIA; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL;

EID: 0031686773     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/515675     Document Type: Article

References (16)

1. Zhu T, Mo H, Wang N, et al. Genotypic and phenotypic characterization of HIV-1 in patients with primary infection. Science 1993;261: 1179-81.
2. Clapham PR, Weiss RA. Immunodeficiency viruses. Spoilt for choice of co-receptors. Nature 1997;388:230-1.
3. Samson M, Libert F, Doranz BJ, et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996;382:722-5.
4. Dean M, Carrington M, Winkler C, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 1996;273:1856-62.
5. Huang Y, Paxton WA, Wolinsky SM, et al. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nature Med 1996;2:1240-3.
6. Paxton WA, Martin SR, Tse D, et al. Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposures. Nature Med 1996;2:412-7.
7. + T lymphocytes from two multiply exposed, uninfected individuals resist infection with primary non-syncytium- inducing isolates of human immunodeficiency virus type 1. J Virol 1996;70:8758-64.
8. Balotta C, Bagnarelli P, Violin M, et al. Homozygous delta 32 deletion of the CCR-5 chemokine receptor gene in an HIV-1-infected patient. AIDS 1997;11:F67-71.
9. Meyer L, Magierowska M, Hubert JB, et al. Early protective effect of CCR-5 delta 32 heterozygosity on HIV-1 disease progression: relationship with viral load. AIDS 1997;11:F73-8.
10. Wu L, Paxton WA, Kassam N, et al. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J Exp Med 1997;185:1681-91.
11. Royce RA, Sena A, Cates W Jr, Cohen MS. Sexual transmission of HIV. N Engl J Med 1997;336:1072-8.
12. Busch MP, Operskalski EA, Mosley JW, et al. Factors influencing human immunodeficiency virus type 1 transmission by blood transfusion. J Infect Dis 1996;174:26-33.
13. Gjerset GF, Pike MC, Mosley JW, et al. Effect of low- and intermediate-purity clotting factor therapy on progression of human immunodeficiency virus infection in congenital clotting disorders. Blood 1994;84: 1666-71.
14. Sabin C, Phillips A, Elford J, Griffiths P, Janossay G, Lee C. The progression of HIV disease in a haemophilic cohort followed for 12 years. Br J Haematol 1993;83:330-3.
15. Simmons G, Wilkinson D, Reeves JD, et al. Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry. J Virol 1996;70:8355-60.
16. Eugen-Olsen J, Iversen AK, Garred P, et al. Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS- free survival and slower CD4 T-cell decline in a cohort of HIV-seropositive individuals. AIDS 1997;11:305-10